GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Purchase Of Business

Immunovia AB (OSTO:IMMNOV) Purchase Of Business : kr0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Purchase Of Business?

Immunovia AB's purchase of business for the three months ended in Mar. 2025 was kr0.00 Mil. It means Immunovia AB spent kr0.00 Mil on purchasing business. Immunovia AB's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Dec. 2024 ), Immunovia AB spent the same money on purchasing business in Mar. 2025 (kr0.00 Mil).

Immunovia AB Purchase Of Business Historical Data

The historical data trend for Immunovia AB's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Purchase Of Business Chart

Immunovia AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Immunovia AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immunovia AB Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunovia AB Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Immunovia AB's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunovia AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Purchase Of Business
Comparable Companies
NGM:LUMITO XSAT:GEAN OSTO:AROC NGM:LEVBIO NGM:ATANA OSTO:SENZA OSTO:PROGEN XSAT:SPERM TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
0G8X:UK 1YR:Germany
Address
Medicon Village, Scheelevagen 8, Lund, SWE, 223 63
Website
https://www.immunovia.com
Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The company is currently developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer.

Immunovia AB Headlines

No Headlines